Cargando…

DETERIORATION OF RESPIRATORY STATUS IN A CVID PATIENT WITH GLILD AND COVID-19

INTRODUCTION: Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) is a serious inflammatory complication of Common Variable Immunodeficiency (CVID), typically requiring immunomodulation in an already immunodeficient patient. CASE DESCRIPTION: A 34-year-old male with CVID, heterozygous for pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimura, N., Jongco, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	M240
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646415/ http://dx.doi.org/10.1016/j.anai.2022.08.889

Ejemplares similares

Heartlogic Heart Failure Index As Covid Index: Predicting Severity Of Covid-19 In Patients With Advanced Heart Failure
por: Panta, Utsab R., et al.
Publicado: (2022)

Prévalence et particularités de l’embolie pulmonaire chez des patients atteints de pneumonies SARS-CoV-2
por: Chaieb, A., et al.
Publicado: (2022)

Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID)
por: Hustings, Nico, et al.
Publicado: (2022)

Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients
por: Tessarin, Giulio, et al.
Publicado: (2023)

Common variable immunodeficiency (CVID) with granulomatous interstitial lung disease (GLILD) and SARS COVID-19 infection: case report and review of literature
por: Pattanaik, Debendra, et al.
Publicado: (2021)

A CASE OF COMMON VARIABLE IMMUNODEFICIENCY (CVID) COMPLICATED BY GRANULOMATOUS LYMPHOCYTIC INTERSTITIAL LUNG DISEASE (GLILD) TRIGGERED BY RECENT COVID-19 INFECTION
por: YAQOOB, ZAID, et al.
Publicado: (2022)

Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers
por: Cinetto, Francesco, et al.
Publicado: (2021)

Phase IIIb, open-label single-arm trial of darunavir/cobicistat (DRV/COBI): Week 48 subgroup analysis of HIV-1-infected treatment-nave adults
por: Tashima, Karen, et al.
Publicado: (2014)

Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review
por: Lamers, Olivia A. C., et al.
Publicado: (2021)

Immune Responses Of CVID Patients To COVID-19 Vaccines
por: Xavier de Medeiros, Giuliana, et al.
Publicado: (2023)

COVID-19 in CVID: a Case Series of 17 Patients
por: Greenmyer, Jacob R., et al.
Publicado: (2021)

POLYMYALGIA RHEUMATICA AFTER MRNA COVID-19 VACCINATION
por: Trotto, N., et al.
Publicado: (2022)

A044 COVID-19 IN CVID: A LARGE HOSPITAL EXPERIENCE
por: Greenmyer, J., et al.
Publicado: (2021)

REDUCED COVID-19 VACCINE RESPONSE IN PATIENT TREATED WITH DUPILUMAB FOR IGG4 RELATED DISEASE.
por: Abadeh, A., et al.
Publicado: (2022)

Assessing Disease Severity in Common Variable Immunodeficiency Disorders (CVID) and CVID-Like Disorders
por: Ameratunga, Rohan
Publicado: (2018)

A CASE OF PULMONARY EMBOLISM POST COVID-19 INFECTION IN A PATIENT WITH STAT3 MUTATION
por: Blunk, H., et al.
Publicado: (2022)

BALANCING GVHD IMMUNOSUPPRESSION AND COVID19 VIRAL REACTIVATION IN A PATIENT WITH ATYPICAL COMPLETE DIGEORGE SYNDROME
por: Breidenbaugh, M., et al.
Publicado: (2022)

CVID Associated with Systemic Amyloidosis
por: Esenboga, Saliha, et al.
Publicado: (2015)

COVID‐19 infection in CVID patients: What we know so far
por: Weifenbach, Niels, et al.
Publicado: (2021)

A Computational Pipeline for the Diagnosis of CVID Patients
por: Emmaneel, Annelies, et al.
Publicado: (2019)

MRNA COVID-19 VACCINE-ASSOCIATED BULLOUS FIXED DRUG ERUPTION
por: Imam, S., et al.
Publicado: (2022)

CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID
por: Kralickova, Pavlina, et al.
Publicado: (2019)

M413 COVID-19 IN A PATIENT WITH CVID AND CONTRAINDICATIONS TO SEVERAL POTENTIAL TREATMENTS
por: Ender, E., et al.
Publicado: (2020)

Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19
por: Van Damme, Karel F. A., et al.
Publicado: (2020)

A CASE SERIES: CHRONIC INDUCIBLE URTICARIA FOLLOWING COVID-19 INFECTION AND MRNA VACCINE
por: Hellu, T., et al.
Publicado: (2022)

Failure of B Cell Tolerance in CVID
por: Richardson, Christopher T., et al.
Publicado: (2019)

SECONDARY URTICARIAL VASCULITIS AND CHRONIC SPONTANEOUS URTICARIA ASSOCIATED WITH COVID-19 VACCINATION
por: Chang, T., et al.
Publicado: (2022)

COVID-19 vaccination rate and side effects in CVID patients over the age of 12
por: Özdemir, Öner, et al.
Publicado: (2022)

M407 COMPLICATIONS OF CORONAVIRUS IN A PATIENT WITH CVID
por: Urschel, D., et al.
Publicado: (2020)

The Successful Vaccination of an IVIgG Naive CVID Patient with an mRNA COVID-19 Vaccine
por: Jalil, Maaz, et al.
Publicado: (2021)

Aplastic anemia in a patient with CVID due to NFKB1 haploinsufficiency
por: Sklarz, Tammarah, et al.
Publicado: (2020)

Identification of CVID Patients With Defects in Immune Repertoire Formation or Specification
por: van Schouwenburg, Pauline A., et al.
Publicado: (2018)

Vedolizumab Therapy in Refractory Enteropathy Associated With CVID
por: Johnson, Dane, et al.
Publicado: (2021)

Lymphoid stromal cells - potential implications for the pathogenesis of CVID
por: Cousin, Victoria N., et al.
Publicado: (2023)

IgG serum levels in CVID patients during pregnancy
por: Pavan-Ramos, Tatiane, et al.
Publicado: (2015)

Safety and tolerability of Evusheld in patients with CVID: The Mayo Clinic experience
por: Squire, Jacqueline D., et al.
Publicado: (2023)

602 Cvid: A Common but Still Underdiagnosed Disease
por: Gallego, Claudia, et al.
Publicado: (2012)

Editorial: Updates on the pathogenesis of common variable immunodeficiency (CVID)
por: Martelius, Timi, et al.
Publicado: (2023)

CVID-associated intestinal disorders in the USIDNET registry: An analysis of disease manifestations, functional status, comorbidities, and treatment
por: Franzblau, Lauren E., et al.
Publicado: (2023)

Dysregulated PI3K Signaling in B Cells of CVID Patients
por: Harder, Ina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r6cjjj4e8itjhsltdju79slg4r